Use of anti-coronavirus antibody testing of cerebrospinal fluid for diagnosis of feline infectious peritonitis involving the central nervous system in cats

Journal of the American Veterinary Medical Association

Volumn 230, Issue 2, 2007, Pages 199-205

  Boettcher, Irene C ^a,c   Steinberg, Tanja ^a   Matiasek, Kaspar ^a   Greene, Craig E ^b   Hartmann, Katrin ^a   Fischer, Andrea ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF GEORGIA   (United States)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PROTEIN; VIRUS ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BRAIN TUMOR; CAT; CAT DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; CORONAVIRUS; CORRELATION ANALYSIS; ERYTHROCYTE COUNT; IMMUNOFLUORESCENCE TEST; LEUKOCYTE COUNT; NONHUMAN; PROSPECTIVE STUDY; PROTEIN CEREBROSPINAL FLUID LEVEL; RNA VIRUS INFECTION; SERUM;

AGE FACTORS; ANIMALS; ANTIBODIES, VIRAL; CATS; CEREBROSPINAL FLUID; CORONAVIRUS, FELINE; DIAGNOSIS, DIFFERENTIAL; FELINE INFECTIOUS PERITONITIS; FEMALE; IMMUNOGLOBULIN G; MALE; NERVOUS SYSTEM DISEASES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEX FACTORS;

CORONAVIRUS; FELIDAE;

EID: 33846201286     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.230.2.199     Document Type: Article

References (55)

1. Rand JS, Parent J, Percy D, et al. Clinical, cerebrospinal fluid, and histological data from thirty-four cats with primary non-inflammatory disease of the central nervous system. Can Vet J 1994;35:174-181.
2. Bradshaw JM, Pearson GR, Graffydd-Jones TJ. A retrospective study of 286 cases of neurological disorders of the cat. J Comp Pathol 2004;131:112-120.
3. Marioni-Henry K, Vite CH, Newton AL, et al. Prevalence of diseases of the spinal cord of cats. J Vet Intern Med 2004;18:851-858.
4. Slauson DO, Finn JP. Meningoencephalitis and panophthalmitis in feline infectious peritonitis. J Am Vet Med Assoc 1972;160:729-734.
5. Kline KL, Joseph RJ, Averill DR. Feline infectious peritonitis with neurological involvement: clinical and pathological findings in 24 cats. J Am Anim Hosp Assoc 1994;30:111-118.
6. Tamke PG, Petersen MG, Dietze AE, et al. Acquired hydrocephalus and hydromyelia in a cat with feline infectious peritonitis: a case report and brief review. Can Vet J 1988;9:997-1000.
7. Barlough JE. Cats, coronaviruses and coronavirus antibody tests. J Small Anim Pract 1985;26:353-362.
8. Gunn-Moore DA, Bennett M, Addie DD, et al. Interpretation of test results for feline infectious peritonitis. Vet Rec 1997;140:219.
9. Hartmann K, Binder C, Hirschberger J, et al. Comparison of different tests to diagnose feline infectious peritonitis. J Vet Intern Med 2003;17:781-790.
10. Baroni M, Heinold Y. A review of the clinical diagnosis of feline infectious peritonitis viral meningoencephalomyelitis. Prog Vet Neurol 1995;6:88-94.
11. Foley JE, Lapointe JM, Koblik P, et al. Diagnostic features of clinical neurologic feline infectious peritonitis. J Vet Intern Med 1998;12:415-423.
12. Addie DD, Jarrett O. Feline coronavirus infections. In: Greene CE, ed. Infectious diseases of the dog and cat. 3rd ed. St Louis, Mo: Saunders Elsevier, 2006;88-102.
13. Dewey CW. Encephalopathies: disorders of the brain. In: Dewey CW, ed. A practical guide to canine and feline neurology. Ames, Iowa: Iowa State Press, 2003;99-178.
14. Foley JE, Leutenegger C. A review of coronavirus infection in the central nervous system of cats and mice. J Vet Intern Med 2001;15:438-444.
15. DVM The newsmagazine of veterinary medicine. Diagnosis of FIP: facing the challenge. Available at: dvmnews.com/dvra/article/articleDetail.jsp?id=85780. Accessed May 19, 2006.
16. Munana KR. Head tilt and nystagmus. In: Platt SR, Olby NJ, eds. BSAVA manual of canine and feline neurology. 2nd ed. Quedgeley, UK: British Small Animal Veterinary Association, 2004;155-171.
17. Vite CH. Inflammatory diseases of the central nervous system. In: Vite CH, ed. Braunds clinical neurology in small animals: localization, diagnosis and treatment. Ithaca, NY: International Veterinary Information Service, 2005. Available at: www.ivis.org. Accessed Oct 14, 2006.
18. Hirschberger J, Hartmann K, Wilhelm N, et al. Clinical symptoms and diagnosis of feline infectious peritonitis. Tieraerztl Prax 1995;23:92-99.
19. Rand JS, Parent J, Jacobs R, et al. Reference intervals for feline cerebrospinal fluid: biochemical and serologic variables, IgG concentration, and electrophoretic fractionation. Am J Vet Res 1990;51:1049-1054.
20. Rand JS, Parent J, Jacobs R, et al. Reference intervals for feline cerebrospinal fluid: cell counts and cytologic features. Am J Vet Res 1990;51:1044-1048.
21. Tipold A. Cerebrospinal fluid. In: Vite CH, ed. Braund's clinical neurology in small animals: localisation, diagnosis and treatment. Ithaca, NY: International Veterinary Information Service, 2003. Available at: www.ivis.org. Accessed Oct 14, 2006.
22. Berg AL, Ekman K, Belak S, et al. Cellular composition and interferon-γ expression of the local inflammatory response in feline infectious peritonitis (FIP). Vet Microbiol 2005;111:15-23.
23. Foley JE, Poland A, Carlson J, et al. Risk factors for feline infectious peritonitis among cats in multiple-cat environments with endemic feline enteric coronavirus. J Am Vet Med Assoc 1997;210:1313-1318.
24. Miller MM, Sweeney CR, Russell GE, et al. Effects of blood contamination of cerebrospinal fluid on western blot analysis for detection of antibodies against Sarcocystis neurona and on albumin quotient and immunoglobulin G index in horses. J Am Vet Med Assoc 1999;215:67-71.
25. Webb AA, Muir GD. The blood-brain barrier and its role in inflammation. J Vet Intern Med 2000;14:399-411.
26. Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical interpretation. Neurobiol Dis 2004;16:1-13.
27. Zameer A, Hoffmann SA. Increased ICAM-1 and VCAM-1 expression in the brains of autoimmune mice. J Neuroimmunol 2003;142:67-74.
28. Reiber H. Flow rate of cerebrospinal fluid (CSF)-a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci 1994;122:189-203.
29. Reiber H. Cerebrospinal fluid physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler 1998;4:99-107.
30. Reiber H. Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. Restor Neurol Neurosci 2003;21:79-96.
31. McReynolds C, Macy D. Feline infectious peritonitis. Part I. Etiology and diagnosis. Compend Contin Educ Pract Vet 1997;19:1007-1014.
32. Kipar A, May H, Menger S, et al. Morphologic features and development of granulomatous vasculitis in feline infectious peritonitis. Vet Pathol 2005;42:321-330.
33. Kipar A, Bellmann S, Kremendahl J, et al. Cellular composition, coronavirus antigen expression and production of specific antibodies in lesions in feline infectious peritonitis. Vet Immunol Immunopathol 1998;65:243-257.
34. Wolfe LG, Griesemer RA. Feline infectious peritonitis: review of gross and histopathologic lesions. J Am Vet Med Assoc 1971;158:987-993.
35. Male DK. Immunology of brain endothelium and the blood-brain barrier. In: Bradbury MWB, ed. Physiology and pharmacology of the blood-brain barrier. Berlin: Springer-Verlag Berlin Heidelberg, 1992;397-404.
36. Tipold A, Pfister H, Vandevelde M. Determination of the IgG index for the detection of intrathecal immunoglobulin synthesis in dogs using an ELISA. Res Vet Sci 1993;54:40-44.
37. Tammer R, Evensen O, Lutz H, et al. Immunohistological demonstration of feline infectious peritonitis virus antigen in paraffin-embedded tissues using feline ascites or murine monoclonal antibodies. Vet Immunol Immunopathol 1995;49:177-182.
38. Lappin MR, Chavkin MJ, Munana KR, et al. Feline ocular and cerebrospinal fluid Toxoplasma gondii-specific humoral immune responses following specific and nonspecific immune stimulation. Vet Immunol Immunopathol 1996;55:23-31.
39. Furr M. Antigen-specific antibodies in cerebrospinal fluid after intramuscular injection of ovalbumin in horses. J Vet Intern Med 2002;16:588-592.
40. Cook AG, Maxwell VB, Donaldson LL, et al. Detection of antibodies against Sarcocystis neurona in cerebrospinal fluid from clinically normal foals. J Am Vet Med Assoc 2002;220:208-211.
41. Witonsky S, Morrow JK, Leger C, et al. Sarcocystis neurona-specific immunoglobulin G in the serum and cerebrospinal fluid of horses administered S neurona vaccine. J Vet Intern Med 2004;18:98-103.
42. Andiman WA. Organism-specific antibody indices, the cerebrospinal fluid-immunoglobulin index and other tools: a clinician's guide to the etiologic diagnosis of central nervous system infection. Pediatr Infect Dis J 1991;10:490-495.
43. Derfuss T, Hohlfeld R, Meinl E. Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response. J Neurol 2005;252:968-971.
44. Reiber H, Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 1991;37:1153-1160.
45. Reiber H, Ungefehr S, Jacobi C. The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 1998;4:111-117.
46. Munana KR, Lappin MR, Powell CC, et al. Sequential measurement of Toxoplasma gondii-specific antibodies in the cerebrospinal fluid of cats with experimentally induced toxoplasmosis. Progr Vet Neurol 1995;6:27-31.
47. Johnson GC, Fenner WR, Krakowka S. Production of immunoglobulin G and increased antiviral antibody in cerebrospinal fluid of dogs with delayed-onset canine distemper viral encephalitis. J Neuroimmunol 1988;17:237-251.
48. Vandevelde M, Zurbriggen A, Steck A, et al. Studies on the intrathecal humoral immune response in canine distemper encephalitis. J Neuroimmunol 1986;11:41-51.
49. Petereit HF, Reske D. Expansion of antibody reactivity in the cerebrospinal fluid of multiple sclerosis patients-follow-up and clinical implications. Cerebrospinal Fluid Res 2005;2:3. Available at: www.cerebrospinalfluidresearch.com/content/2/1/3. Accessed Oct 14, 2006.
50. Davies DC. Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat 2002;200:639-646.
51. Schneider SW, Ludwig T, Tatenhorst L, et al. Glioblastoma cells release factors that disrupt blood-brain barrier features. Acta Neuropathol 2004;107:272-276.
52. Bayens-Simmonds J, Boisvert DP, Castro ME, et al. A feline model for experimental studies of peritumor brain edema. J Neurooncol 1988;6:371-378.
53. Moore GJ, Bagley RS, Harrington ML, et al. Intracranial tumors. Vet Clin North Am Small Anim Pract 1996;26:759-777.
54. Hartmann K. Feline infectious peritonitis. Vet Clin North Am Small Anim Pract 2005;35:39-79.
55. Sparkes AH, Gruffydd Jones TJ, Harbour DA. An appraisal of the value of laboratory tests in the diagnosis of feline infectious peritonitis. J Am Anim Hosp Assoc 1994;30:345-350.